For the quarter ending 2026-03-31, CERO has $2,205,110 in assets. $11,463,865 in debts.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash, restricted cash, and cash equivalents | 857,489 | 1,662,380 | 2,022,072 | 3,302,674 |
| Prepaid expenses and other current assets | 716,909 | 1,071,900 | 531,827 | 443,892 |
| Investment in equity securities, at cost | - | - | - | 500,000 |
| Deferred offering costs | - | - | - | 0 |
| Total current assets | 1,574,398 | 2,734,280 | 2,553,899 | 4,246,566 |
| Deferred offering costs, net of current portion | - | - | 174,505 | 500,000 |
| Operating lease right-of-use assets | 446,263 | 660,706 | 869,538 | 1,072,950 |
| Property and equipment, net | 184,449 | 246,148 | 313,452 | 382,806 |
| Total assets | 2,205,110 | 3,641,134 | 3,911,394 | 6,202,322 |
| Accounts payable | 7,686,681 | 7,580,899 | 7,077,342 | 6,213,045 |
| Accrued liabilities | 500,788 | 363,811 | 340,691 | 365,060 |
| Insurance payable | 195,329 | 338,279 | - | - |
| Operating lease liability | 461,580 | 699,107 | 931,023 | 934,310 |
| Derivative liabilities | 2,396,722 | - | - | - |
| Earnout liability | 500 | 20,000 | 20,000 | 20,000 |
| Deemed dividend common stock liability, 692 shares | 85,500 | 85,500 | 85,500 | 85,500 |
| Total current liabilities | 11,327,100 | 9,087,596 | 8,454,556 | 7,617,915 |
| Operating lease liability, net of current portion | - | - | - | 218,308 |
| Convertible notes payable, net | 136,765 | - | - | - |
| Total liabilities | 11,463,865 | 9,087,596 | 8,454,556 | 7,836,223 |
| Preferred stock, par value 0.0001 authorized 10,000,000 shares-Series CConvertible Preferred Stock | 2,292 | 2,292 | 2,292 | 46,935 |
| Preferred stock, par value 0.0001 authorized 10,000,000 shares-Series DConvertible Preferred Stock | 4,002,333 | 4,047,699 | 7,408,866 | 7,240,180 |
| Convertible preferred stock, value-Series BConvertible Preferred Stock | - | - | - | 0 |
| Preferred stock, par value 0.0001 authorized 10,000,000 shares-Series EConvertible Preferred Stock | 1,926,133 | 1,926,133 | - | - |
| Preferred stock, par value 0.0001 authorized 10,000,000 shares-Series AConvertible Preferred Stock | 1,287,315 | 1,287,315 | 1,287,315 | 1,287,315 |
| Class a common stock 0.0001 par value 1,000,000,000 shares authorized 36,010,373 and 21,102,671 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively-Common Class A | 3,601 | 2,110 | 150 | 119 |
| Additional paid-in capital | 80,288,145 | 78,126,104 | 73,055,709 | 71,311,399 |
| Stock subscription receivable | 44,545 | - | - | 78,750 |
| Accumulated deficit | -96,724,029 | -90,838,115 | -86,297,494 | -81,441,099 |
| Total stockholders deficit | -9,258,755 | -5,446,462 | -4,543,162 | -1,633,901 |
| Total liabilities and stockholders deficit | 2,205,110 | 3,641,134 | 3,911,394 | 6,202,322 |
CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CERO THERAPEUTICS HOLDINGS, INC. (CERO)